Xilio Therapeutics, Inc.

Q4 2022 13F Holders

Symbol
XLO
CUSIP
98422T100
Type
Equity
Class
COM
Num filings
30
Total reported value, excl. options
$42.9 M
Manager Report Date Value ($000) Shares Option Type